Industry Research Reports

Home > Reports > Service & Software > Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Mammalian CDMO Service - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Industry: Service & Software

Published Date: 2026-01-19

Pages: 133 Pages

Report ld: 5757609

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.

The North American market for Mammalian CDMO Service was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.

The Asia-Pacific market for Mammalian CDMO Service was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.

The European market for Mammalian CDMO Service was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.

The global key companies in the Mammalian CDMO Service market include Cytovance Biologics, 3P Bio, AGC Biologics, KBI Biopharma, GTP Bioways, Tanvex CDMO, Samsung Biologics, WuXi Biologics, PlantForm Corporation, Gedeon Richter, etc. In 2025, the five largest players accounted for approximately % of revenue.

This report provides a comprehensive view of the global market for Mammalian CDMO Service, covering total sales revenue, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.

The Mammalian CDMO Service market size, estimations, and forecasts are presented in terms of sales revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Mammalian CDMO Service.

MARKET SEGMENTATION

By Company

Cytovance Biologics
3P Bio
AGC Biologics
KBI Biopharma
GTP Bioways
Tanvex CDMO
Samsung Biologics
WuXi Biologics
PlantForm Corporation
Gedeon Richter
Lonza
Novartis
Rentschler Biopharma SE
Northway Biotech
Boehringer Ingelheim
Cambrex
FUJIFILM Diosynth Biotechnologies
GBI
Scorpius BioManufacturing

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Cell Line Development
Genomic Analysis
Process Development
Analytical Services
Formulation Development
Manufacturing
Others

Segment by Application

Contract Research Organizations (CROs)
Pharmaceutical
Biotechnology Companies
Government Agencies
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the scope of the report and the global market size (value). It also summarizes market dynamics and recent developments; identifies key drivers and restraints; outlines challenges and risks for players; reviews relevant industry policies.

Chapter 2: Provides a detailed analysis of the Mammalian CDMO Service companies' competitive landscape—including revenue shares, recent development plans, and mergers and acquisitions (M&A).

Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.

Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.

Chapter 5: Presents Mammalian CDMO Service revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.

Chapter 6: Presents Mammalian CDMO Service revenue at the country level. It provides segmented data by Type and by Application for each country/region.

Chapter 7: Profiles key players, detailing the main companies' product revenue, gross margin, product portfolios, recent developments, etc.

Chapter 8: Analysis of Value Chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Mammalian CDMO Service Product Introduction

1.2 Global Mammalian CDMO Service Market Size Forecast (2021–2032)

1.3 Mammalian CDMO Service Market Trends & Drivers

1.3.1 Mammalian CDMO Service Industry Trends

1.3.2 Mammalian CDMO Service Market Drivers & Opportunities

1.3.3 Mammalian CDMO Service Market Challenges

1.3.4 Mammalian CDMO Service Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Mammalian CDMO Service Players Revenue Ranking (2025)

2.2 Global Mammalian CDMO Service Revenue by Company (2021–2026)

2.3 Key Companies’ R&D and Operations Footprint and Headquarters

2.4 Key Companies Mammalian CDMO Service Product Offerings

2.5 Key Companies General Availability (GA) Timeline for Mammalian CDMO Service

2.6 Mammalian CDMO Service Market Competitive Analysis

2.6.1 Mammalian CDMO Service Market Concentration Rate (2021–2026)

2.6.2 Top 5 and Top 10 Global Companies by Mammalian CDMO Service Revenue in 2025

2.6.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mammalian CDMO Service revenue, 2025

2.7 Mergers & Acquisitions and Expansion

3 Segmentation Mammalian CDMO Service Market Classification

3.1 Introduction by Type

3.1.1 Cell Line Development

3.1.2 Genomic Analysis

3.1.3 Process Development

3.1.4 Analytical Services

3.1.5 Formulation Development

3.1.6 Manufacturing

3.1.7 Others

3.1.8 Global Mammalian CDMO Service Sales Value by Type

3.1.8.1 Global Mammalian CDMO Service Sales Value by Type (2021 vs 2025 vs 2032)

3.1.8.2 Global Mammalian CDMO Service Sales Value, by Type (2021–2032)

3.1.8.3 Global Mammalian CDMO Service Sales Value, by Type (%), 2021–2032

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Contract Research Organizations (CROs)

4.1.2 Pharmaceutical

4.1.3 Biotechnology Companies

4.1.4 Government Agencies

4.1.5 Others

4.2 Global Mammalian CDMO Service Sales Value by Application

4.2.1 Global Mammalian CDMO Service Sales Value by Application (2021 vs 2025 vs 2032)

4.2.2 Global Mammalian CDMO Service Sales Value by Application (2021–2032)

4.2.3 Global Mammalian CDMO Service Sales Value by Application (%), 2021–2032

5 Segmentation by Region

5.1 Global Mammalian CDMO Service Sales Value by Region

5.1.1 Global Mammalian CDMO Service Sales Value by Region: 2021 vs 2025 vs 2032

5.1.2 Global Mammalian CDMO Service Sales Value by Region (2021–2026)

5.1.3 Global Mammalian CDMO Service Sales Value by Region (2027–2032)

5.1.4 Global Mammalian CDMO Service Sales Value by Region (%), 2021–2032

5.2 North America

5.2.1 North America Mammalian CDMO Service Sales Value, 2021–2032

5.2.2 North America Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

5.3 Europe

5.3.1 Europe Mammalian CDMO Service Sales Value, 2021–2032

5.3.2 Europe Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

5.4 Asia Pacific

5.4.1 Asia Pacific Mammalian CDMO Service Sales Value, 2021–2032

5.4.2 Asia Pacific Mammalian CDMO Service Sales Value by Subregion (%), 2025 vs 2032

5.5 South America

5.5.1 South America Mammalian CDMO Service Sales Value, 2021–2032

5.5.2 South America Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

5.6 Middle East & Africa

5.6.1 Middle East & Africa Mammalian CDMO Service Sales Value, 2021–2032

5.6.2 Middle East & Africa Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Mammalian CDMO Service Sales Value Growth Trends, 2021 vs 2025 vs 2032

6.2 Key Countries/Regions Mammalian CDMO Service Sales Value, 2021–2032

6.3 United States

6.3.1 United States Mammalian CDMO Service Sales Value, 2021–2032

6.3.2 United States Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.3.3 United States Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

6.4 Europe

6.4.1 Europe Mammalian CDMO Service Sales Value, 2021–2032

6.4.2 Europe Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.4.3 Europe Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

6.5 China

6.5.1 China Mammalian CDMO Service Sales Value, 2021–2032

6.5.2 China Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.5.3 China Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

6.6 Japan

6.6.1 Japan Mammalian CDMO Service Sales Value, 2021–2032

6.6.2 Japan Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.6.3 Japan Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

6.7 South Korea

6.7.1 South Korea Mammalian CDMO Service Sales Value, 2021–2032

6.7.2 South Korea Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.7.3 South Korea Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

6.8 Southeast Asia

6.8.1 Southeast Asia Mammalian CDMO Service Sales Value, 2021–2032

6.8.2 Southeast Asia Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.8.3 Southeast Asia Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

6.9 India

6.9.1 India Mammalian CDMO Service Sales Value, 2021–2032

6.9.2 India Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

6.9.3 India Mammalian CDMO Service Sales Value by Application, 2025 vs 2032

7 Company Profiles

7.1 Cytovance Biologics

7.1.1 Cytovance Biologics Profile

7.1.2 Cytovance Biologics Main Business

7.1.3 Cytovance Biologics Mammalian CDMO Service Products, Services, and Solutions

7.1.4 Cytovance Biologics Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.1.5 Cytovance Biologics Recent Developments

7.2 3P Bio

7.2.1 3P Bio Profile

7.2.2 3P Bio Main Business

7.2.3 3P Bio Mammalian CDMO Service Products, Services, and Solutions

7.2.4 3P Bio Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.2.5 3P Bio Recent Developments

7.3 AGC Biologics

7.3.1 AGC Biologics Profile

7.3.2 AGC Biologics Main Business

7.3.3 AGC Biologics Mammalian CDMO Service Products, Services, and Solutions

7.3.4 AGC Biologics Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.3.5 AGC Biologics Recent Developments

7.4 KBI Biopharma

7.4.1 KBI Biopharma Profile

7.4.2 KBI Biopharma Main Business

7.4.3 KBI Biopharma Mammalian CDMO Service Products, Services, and Solutions

7.4.4 KBI Biopharma Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.4.5 KBI Biopharma Recent Developments

7.5 GTP Bioways

7.5.1 GTP Bioways Profile

7.5.2 GTP Bioways Main Business

7.5.3 GTP Bioways Mammalian CDMO Service Products, Services, and Solutions

7.5.4 GTP Bioways Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.5.5 GTP Bioways Recent Developments

7.6 Tanvex CDMO

7.6.1 Tanvex CDMO Profile

7.6.2 Tanvex CDMO Main Business

7.6.3 Tanvex CDMO Mammalian CDMO Service Products, Services, and Solutions

7.6.4 Tanvex CDMO Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.6.5 Tanvex CDMO Recent Developments

7.7 Samsung Biologics

7.7.1 Samsung Biologics Profile

7.7.2 Samsung Biologics Main Business

7.7.3 Samsung Biologics Mammalian CDMO Service Products, Services, and Solutions

7.7.4 Samsung Biologics Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.7.5 Samsung Biologics Recent Developments

7.8 WuXi Biologics

7.8.1 WuXi Biologics Profile

7.8.2 WuXi Biologics Main Business

7.8.3 WuXi Biologics Mammalian CDMO Service Products, Services, and Solutions

7.8.4 WuXi Biologics Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.8.5 WuXi Biologics Recent Developments

7.9 PlantForm Corporation

7.9.1 PlantForm Corporation Profile

7.9.2 PlantForm Corporation Main Business

7.9.3 PlantForm Corporation Mammalian CDMO Service Products, Services, and Solutions

7.9.4 PlantForm Corporation Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.9.5 PlantForm Corporation Recent Developments

7.10 Gedeon Richter

7.10.1 Gedeon Richter Profile

7.10.2 Gedeon Richter Main Business

7.10.3 Gedeon Richter Mammalian CDMO Service Products, Services, and Solutions

7.10.4 Gedeon Richter Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.10.5 Gedeon Richter Recent Developments

7.11 Lonza

7.11.1 Lonza Profile

7.11.2 Lonza Main Business

7.11.3 Lonza Mammalian CDMO Service Products, Services, and Solutions

7.11.4 Lonza Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.11.5 Lonza Recent Developments

7.12 Novartis

7.12.1 Novartis Profile

7.12.2 Novartis Main Business

7.12.3 Novartis Mammalian CDMO Service Products, Services, and Solutions

7.12.4 Novartis Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.12.5 Novartis Recent Developments

7.13 Rentschler Biopharma SE

7.13.1 Rentschler Biopharma SE Profile

7.13.2 Rentschler Biopharma SE Main Business

7.13.3 Rentschler Biopharma SE Mammalian CDMO Service Products, Services, and Solutions

7.13.4 Rentschler Biopharma SE Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.13.5 Rentschler Biopharma SE Recent Developments

7.14 Northway Biotech

7.14.1 Northway Biotech Profile

7.14.2 Northway Biotech Main Business

7.14.3 Northway Biotech Mammalian CDMO Service Products, Services, and Solutions

7.14.4 Northway Biotech Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.14.5 Northway Biotech Recent Developments

7.15 Boehringer Ingelheim

7.15.1 Boehringer Ingelheim Profile

7.15.2 Boehringer Ingelheim Main Business

7.15.3 Boehringer Ingelheim Mammalian CDMO Service Products, Services, and Solutions

7.15.4 Boehringer Ingelheim Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.15.5 Boehringer Ingelheim Recent Developments

7.16 Cambrex

7.16.1 Cambrex Profile

7.16.2 Cambrex Main Business

7.16.3 Cambrex Mammalian CDMO Service Products, Services, and Solutions

7.16.4 Cambrex Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.16.5 Cambrex Recent Developments

7.17 FUJIFILM Diosynth Biotechnologies

7.17.1 FUJIFILM Diosynth Biotechnologies Profile

7.17.2 FUJIFILM Diosynth Biotechnologies Main Business

7.17.3 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Products, Services, and Solutions

7.17.4 FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.17.5 FUJIFILM Diosynth Biotechnologies Recent Developments

7.18 GBI

7.18.1 GBI Profile

7.18.2 GBI Main Business

7.18.3 GBI Mammalian CDMO Service Products, Services, and Solutions

7.18.4 GBI Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.18.5 GBI Recent Developments

7.19 Scorpius BioManufacturing

7.19.1 Scorpius BioManufacturing Profile

7.19.2 Scorpius BioManufacturing Main Business

7.19.3 Scorpius BioManufacturing Mammalian CDMO Service Products, Services, and Solutions

7.19.4 Scorpius BioManufacturing Mammalian CDMO Service Revenue (US$ Million), 2021–2026

7.19.5 Scorpius BioManufacturing Recent Developments

8 Industry Chain Analysis

8.1 Mammalian CDMO Service Value Chain

8.2 Mammalian CDMO Service Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Key Suppliers of Raw Materials

8.2.3 Cost Structure

8.3 Midstream Analysis

8.4 Downstream (Customer) Analysis

8.5 Sales Model and Sales Channelss

8.5.1 Mammalian CDMO Service Sales Model

8.5.2 Sales Channels

8.5.3 Mammalian CDMO Service Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Mammalian CDMO Service Market Trends

Table 2. Mammalian CDMO Service Market Drivers & Opportunities

Table 3. Mammalian CDMO Service Market Challenges

Table 4. Mammalian CDMO Service Market Restraints

Table 5. Global Mammalian CDMO Service Revenue by Company (US$ Million), 2021–2026

Table 6. Global Mammalian CDMO Service Revenue Market Share by Company (2021–2026)

Table 7. Key Companies’ R&D and Operations Footprint and Headquarters

Table 8. Key Companies Mammalian CDMO Service Product Type

Table 9. Key Companies General Availability (GA) Timeline for Mammalian CDMO Service

Table 10. Global Mammalian CDMO Service Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Mammalian CDMO Service revenue, 2025

Table 12. Mergers & Acquisitions and Expansion Plans

Table 13. Global Mammalian CDMO Service Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)

Table 14. Global Mammalian CDMO Service Sales Value by Type (US$ Million), 2021–2026

Table 15. Global Mammalian CDMO Service Sales Value by Type (US$ Million), 2027–2032

Table 16. Global Mammalian CDMO Service Sales Market Share in Value by Type (2021–2026)

Table 17. Global Mammalian CDMO Service Sales Market Share in Value by Type (2027–2032)

Table 18. Global Mammalian CDMO Service Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)

Table 19. Global Mammalian CDMO Service Sales Value by Application (US$ Million), 2021–2026

Table 20. Global Mammalian CDMO Service Sales Value by Application (US$ Million), 2027–2032

Table 21. Global Mammalian CDMO Service Sales Market Share in Value by Application (2021–2026)

Table 22. Global Mammalian CDMO Service Sales Market Share in Value by Application (2027–2032)

Table 23. Global Mammalian CDMO Service Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032

Table 24. Global Mammalian CDMO Service Sales Value by Region (US$ Million), 2021–2026

Table 25. Global Mammalian CDMO Service Sales Value by Region (US$ Million), 2027–2032

Table 26. Global Mammalian CDMO Service Sales Value by Region (%), 2021–2026

Table 27. Global Mammalian CDMO Service Sales Value by Region (%), 2027–2032

Table 28. Key Countries/Regions Mammalian CDMO Service Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032

Table 29. Key Countries/Regions Mammalian CDMO Service Sales Value, (US$ Million), 2021–2026

Table 30. Key Countries/Regions Mammalian CDMO Service Sales Value, (US$ Million), 2027–2032

Table 31. Cytovance Biologics Basic Information List

Table 32. Cytovance Biologics Description and Business Overview

Table 33. Cytovance Biologics Mammalian CDMO Service Products, Services, and Solutions

Table 34. Revenue (US$ Million) in Mammalian CDMO Service Business of Cytovance Biologics (2021–2026)

Table 35. Cytovance Biologics Recent Developments

Table 36. 3P Bio Basic Information List

Table 37. 3P Bio Description and Business Overview

Table 38. 3P Bio Mammalian CDMO Service Products, Services, and Solutions

Table 39. Revenue (US$ Million) in Mammalian CDMO Service Business of 3P Bio (2021–2026)

Table 40. 3P Bio Recent Developments

Table 41. AGC Biologics Basic Information List

Table 42. AGC Biologics Description and Business Overview

Table 43. AGC Biologics Mammalian CDMO Service Products, Services, and Solutions

Table 44. Revenue (US$ Million) in Mammalian CDMO Service Business of AGC Biologics (2021–2026)

Table 45. AGC Biologics Recent Developments

Table 46. KBI Biopharma Basic Information List

Table 47. KBI Biopharma Description and Business Overview

Table 48. KBI Biopharma Mammalian CDMO Service Products, Services, and Solutions

Table 49. Revenue (US$ Million) in Mammalian CDMO Service Business of KBI Biopharma (2021–2026)

Table 50. KBI Biopharma Recent Developments

Table 51. GTP Bioways Basic Information List

Table 52. GTP Bioways Description and Business Overview

Table 53. GTP Bioways Mammalian CDMO Service Products, Services, and Solutions

Table 54. Revenue (US$ Million) in Mammalian CDMO Service Business of GTP Bioways (2021–2026)

Table 55. GTP Bioways Recent Developments

Table 56. Tanvex CDMO Basic Information List

Table 57. Tanvex CDMO Description and Business Overview

Table 58. Tanvex CDMO Mammalian CDMO Service Products, Services, and Solutions

Table 59. Revenue (US$ Million) in Mammalian CDMO Service Business of Tanvex CDMO (2021–2026)

Table 60. Tanvex CDMO Recent Developments

Table 61. Samsung Biologics Basic Information List

Table 62. Samsung Biologics Description and Business Overview

Table 63. Samsung Biologics Mammalian CDMO Service Products, Services, and Solutions

Table 64. Revenue (US$ Million) in Mammalian CDMO Service Business of Samsung Biologics (2021–2026)

Table 65. Samsung Biologics Recent Developments

Table 66. WuXi Biologics Basic Information List

Table 67. WuXi Biologics Description and Business Overview

Table 68. WuXi Biologics Mammalian CDMO Service Products, Services, and Solutions

Table 69. Revenue (US$ Million) in Mammalian CDMO Service Business of WuXi Biologics (2021–2026)

Table 70. WuXi Biologics Recent Developments

Table 71. PlantForm Corporation Basic Information List

Table 72. PlantForm Corporation Description and Business Overview

Table 73. PlantForm Corporation Mammalian CDMO Service Products, Services, and Solutions

Table 74. Revenue (US$ Million) in Mammalian CDMO Service Business of PlantForm Corporation (2021–2026)

Table 75. PlantForm Corporation Recent Developments

Table 76. Gedeon Richter Basic Information List

Table 77. Gedeon Richter Description and Business Overview

Table 78. Gedeon Richter Mammalian CDMO Service Products, Services, and Solutions

Table 79. Revenue (US$ Million) in Mammalian CDMO Service Business of Gedeon Richter (2021–2026)

Table 80. Gedeon Richter Recent Developments

Table 81. Lonza Basic Information List

Table 82. Lonza Description and Business Overview

Table 83. Lonza Mammalian CDMO Service Products, Services, and Solutions

Table 84. Revenue (US$ Million) in Mammalian CDMO Service Business of Lonza (2021–2026)

Table 85. Lonza Recent Developments

Table 86. Novartis Basic Information List

Table 87. Novartis Description and Business Overview

Table 88. Novartis Mammalian CDMO Service Products, Services, and Solutions

Table 89. Revenue (US$ Million) in Mammalian CDMO Service Business of Novartis (2021–2026)

Table 90. Novartis Recent Developments

Table 91. Rentschler Biopharma SE Basic Information List

Table 92. Rentschler Biopharma SE Description and Business Overview

Table 93. Rentschler Biopharma SE Mammalian CDMO Service Products, Services, and Solutions

Table 94. Revenue (US$ Million) in Mammalian CDMO Service Business of Rentschler Biopharma SE (2021–2026)

Table 95. Rentschler Biopharma SE Recent Developments

Table 96. Northway Biotech Basic Information List

Table 97. Northway Biotech Description and Business Overview

Table 98. Northway Biotech Mammalian CDMO Service Products, Services, and Solutions

Table 99. Revenue (US$ Million) in Mammalian CDMO Service Business of Northway Biotech (2021–2026)

Table 100. Northway Biotech Recent Developments

Table 101. Boehringer Ingelheim Basic Information List

Table 102. Boehringer Ingelheim Description and Business Overview

Table 103. Boehringer Ingelheim Mammalian CDMO Service Products, Services, and Solutions

Table 104. Revenue (US$ Million) in Mammalian CDMO Service Business of Boehringer Ingelheim (2021–2026)

Table 105. Boehringer Ingelheim Recent Developments

Table 106. Cambrex Basic Information List

Table 107. Cambrex Description and Business Overview

Table 108. Cambrex Mammalian CDMO Service Products, Services, and Solutions

Table 109. Revenue (US$ Million) in Mammalian CDMO Service Business of Cambrex (2021–2026)

Table 110. Cambrex Recent Developments

Table 111. FUJIFILM Diosynth Biotechnologies Basic Information List

Table 112. FUJIFILM Diosynth Biotechnologies Description and Business Overview

Table 113. FUJIFILM Diosynth Biotechnologies Mammalian CDMO Service Products, Services, and Solutions

Table 114. Revenue (US$ Million) in Mammalian CDMO Service Business of FUJIFILM Diosynth Biotechnologies (2021–2026)

Table 115. FUJIFILM Diosynth Biotechnologies Recent Developments

Table 116. GBI Basic Information List

Table 117. GBI Description and Business Overview

Table 118. GBI Mammalian CDMO Service Products, Services, and Solutions

Table 119. Revenue (US$ Million) in Mammalian CDMO Service Business of GBI (2021–2026)

Table 120. GBI Recent Developments

Table 121. Scorpius BioManufacturing Basic Information List

Table 122. Scorpius BioManufacturing Description and Business Overview

Table 123. Scorpius BioManufacturing Mammalian CDMO Service Products, Services, and Solutions

Table 124. Revenue (US$ Million) in Mammalian CDMO Service Business of Scorpius BioManufacturing (2021–2026)

Table 125. Scorpius BioManufacturing Recent Developments

Table 126. Revenue (US$ Million) in Mammalian CDMO Service Business of Company 40 (2021–2026)

Table 127. Company 40 Recent Developments

Table 128. Key Raw Materials Lists

Table 129. Key Suppliers of Raw Materials Lists

Table 130. Mammalian CDMO Service Downstream Customers

Table 131. Mammalian CDMO Service Distributors List

Table 132. Research Programs/Design for This Report

Table 133. Key Data Information from Secondary Sources

Table 134. Key Data Information from Primary Sources

List of Figures

Figure 1. Mammalian CDMO Service Product Picture

Figure 2. Global Mammalian CDMO Service Sales Value, 2021 vs 2025 vs 2032 (US$ Million)

Figure 3. Global Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 4. Mammalian CDMO Service Report Years Considered

Figure 5. Global Mammalian CDMO Service Players Revenue Ranking (US$ Million), 2025

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Mammalian CDMO Service Revenue in 2025

Figure 7. Mammalian CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

Figure 8. Cell Line Development Picture

Figure 9. Genomic Analysis Picture

Figure 10. Process Development Picture

Figure 11. Analytical Services Picture

Figure 12. Formulation Development Picture

Figure 13. Manufacturing Picture

Figure 14. Others Picture

Figure 15. Global Mammalian CDMO Service Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032

Figure 16. Global Mammalian CDMO Service Sales Value Market Share by Type, 2025 & 2032

Figure 17. Product Picture of Contract Research Organizations (CROs)

Figure 18. Product Picture of Pharmaceutical

Figure 19. Product Picture of Biotechnology Companies

Figure 20. Product Picture of Government Agencies

Figure 21. Product Picture of Others

Figure 22. Global Mammalian CDMO Service Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Mammalian CDMO Service Sales Value Market Share by Application, 2025 & 2032

Figure 24. North America Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 25. North America Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

Figure 26. Europe Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 27. Europe Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

Figure 28. Asia Pacific Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 29. Asia Pacific Mammalian CDMO Service Sales Value by Subregion (%), 2025 vs 2032

Figure 30. South America Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 31. South America Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

Figure 32. Middle East & Africa Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 33. Middle East & Africa Mammalian CDMO Service Sales Value by Country (%), 2025 vs 2032

Figure 34. Key Countries/Regions Mammalian CDMO Service Sales Value (%), 2021–2032

Figure 35. United States Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 36. United States Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 37. United States Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 38. Europe Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 39. Europe Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 40. Europe Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 41. China Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 42. China Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 43. China Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 44. Japan Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 45. Japan Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 46. Japan Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 47. South Korea Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 48. South Korea Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 49. South Korea Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 50. Southeast Asia Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 51. Southeast Asia Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 52. Southeast Asia Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 53. India Mammalian CDMO Service Sales Value (US$ Million), 2021–2032

Figure 54. India Mammalian CDMO Service Sales Value by Type (%), 2025 vs 2032

Figure 55. India Mammalian CDMO Service Sales Value by Application (%), 2025 vs 2032

Figure 56. Mammalian CDMO Service Value Chain

Figure 57. Mammalian CDMO Service Cost Structure

Figure 58. Channels of Distribution (Direct Sales, and Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Mammalian CDMO Service market? zhanKai

The top companies in the global Mammalian CDMO Service market are Cytovance Biologics、3P Bio、AGC Biologics.

Related Reports

Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-31
Pages: 148
USD 4900.00
(Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 105
USD 4250.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-16
Pages: 122
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 110
USD 4250.00
(Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 158
USD 4900.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-11
Pages: 124
USD 3950.00
(Single User License)
Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-11
Pages: 97
USD 2900.00
(Single User License)
Global Mammalian CDMO Service Market Insights, Forecast to 2030
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-04-10
Pages: 154
USD 4900.00
(Single User License)
Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-04-10
Pages: 126
USD 4350.00
(Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-04-10
Pages: 124
USD 3950.00
(Single User License)

Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Mammalian CDMO Service market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-31
Pages: 148
USD 4900.00 (Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Mammalian CDMO Service market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 105
USD 4250.00 (Single User License)
Global Mammalian CDMO Service Market Research Report 2026
The global Mammalian CDMO Service market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-16
Pages: 122
USD 2900.00 (Single User License)
Global Mammalian CDMO Service Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Mammalian CDMO Service market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 110
USD 4250.00 (Single User License)
Global Mammalian CDMO Service Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 158
USD 4900.00 (Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-11
Pages: 124
USD 3950.00 (Single User License)
Global Mammalian CDMO Service Market Research Report 2025
The global market for Mammalian CDMO Service was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-11
Pages: 97
USD 2900.00 (Single User License)
Global Mammalian CDMO Service Market Insights, Forecast to 2030
The global Mammalian CDMO Service market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-04-10
Pages: 154
USD 4900.00 (Single User License)
Global and United States Mammalian CDMO Service Market Report & Forecast 2024-2030
The global Mammalian CDMO Service revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-04-10
Pages: 126
USD 4350.00 (Single User License)
Mammalian CDMO Service- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
The global market for Mammalian CDMO Service was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the forecast period 2024-2030.
Published: 2024-04-10
Pages: 124
USD 3950.00 (Single User License)